Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury

References

• Liu WZ, Ma ZJ, Li JR, Kang XW. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res Ther. 2021;12(1):102. doi:10.1186/s13287-021-02153-8
   PubMed Web of Science ®Google Scholar
• Yang B, Zhang F, Cheng F, et al. Strategies and prospects of effective neural circuits reconstruction after spinal cord injury. Cell Death Dis. 2020;11(6):439. doi:10.1038/s41419-020-2620-z
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sakai T. Current concepts of stem cell therapy for chronic spinal cord injury. Int J Mol Sci. 2021;22(14):7435. doi:10.3390/ijms22147435
   PubMed Web of Science ®Google Scholar
• Singh A, Tetreault L, Kalsi-Ryan S, Nouri A, Fehlings MG. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol. 2014;6:309–331. doi:10.2147/CLEP.S68889
   PubMed Web of Science ®Google Scholar
• Fakhri S, Abbaszadeh F, Jorjani M. On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: a mechanistic review. Biomed Pharmacother. 2021;139:111563.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Y, Wang Y, Qian T. Inflammatory response to spinal cord injury and its treatment. World Neurosurg. 2021;155:19–31. doi:10.1016/j.wneu.2021.07.148
   PubMed Web of Science ®Google Scholar
• Torregrossa F, Salli M, Grasso G. Emerging therapeutic strategies for traumatic spinal cord injury. World Neurosurg. 2020;140:591–601. doi:10.1016/j.wneu.2020.03.199
   PubMed Web of Science ®Google Scholar
• Han T, Song P, Wu Z, et al. MSC secreted extracellular vesicles carrying TGF-beta upregulate Smad 6 expression and promote the regrowth of neurons in spinal cord injured rats. Stem Cell Rev Rep. 2021. doi:10.1007/s12015-021-10219-6
   PubMed Web of Science ®Google Scholar
• Abbaszadeh F, Fakhri S, Khan H. Targeting apoptosis and autophagy following spinal cord injury: therapeutic approaches to polyphenols and candidate phytochemicals. Pharmacol Res. 2020;160:105069. doi:10.1016/j.phrs.2020.105069
   PubMed Web of Science ®Google Scholar
• Lin J, Xiong Z, Gu J, et al. Sirtuins: potential therapeutic targets for defense against oxidative stress in spinal cord injury. Oxid Med Cell Longev. 2021;2021:7207692. doi:10.1155/2021/7207692
   PubMed Web of Science ®Google Scholar
• Hachem LD, Fehlings MG. Pathophysiology of spinal cord injury. Neurosurg Clin N Am. 2021;32(3):305–313. doi:10.1016/j.nec.2021.03.002
   PubMed Web of Science ®Google Scholar
• Piri SM, Ghodsi Z, Shool S, et al. Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review. Eur Spine J. 2021;30(6):1474–1494. doi:10.1007/s00586-021-06718-2
   PubMed Web of Science ®Google Scholar
• Vafaei-Nezhad S, Pour Hassan M, Noroozian M, et al. A review of low-level laser therapy for spinal cord injury: challenges and safety. J Lasers Med Sci. 2020;11(4):363–368. doi:10.34172/jlms.2020.59
   PubMed Web of Science ®Google Scholar
• David S, Lopez-Vales R. Bioactive lipid mediators in the initiation and resolution of inflammation after spinal cord injury. Neuroscience. 2021;466:273–297. doi:10.1016/j.neuroscience.2021.04.026
   PubMed Web of Science ®Google Scholar
• Chio JCT, Xu KJ, Popovich P, David S, Fehlings MG. Neuroimmunological therapies for treating spinal cord injury: evidence and future perspectives. Exp Neurol. 2021;341:113704. doi:10.1016/j.expneurol.2021.113704
   PubMed Web of Science ®Google Scholar
• Takami T, Shimokawa N, Parthiban J, Zileli M, Ali S. Pharmacologic and regenerative cell therapy for spinal cord injury: WFNS spine committee recommendations. Neurospine. 2020;17(4):785–796. doi:10.14245/ns.2040408.204
   PubMed Web of Science ®Google Scholar
• Sandean D. Management of acute spinal cord injury: a summary of the evidence pertaining to the acute management, operative and non-operative management. World J Orthop. 2020;11(12):573–583. doi:10.5312/wjo.v11.i12.573
   PubMed Web of Science ®Google Scholar
• Canseco JA, Karamian BA, Bowles DR, et al. Updated review: the steroid controversy for management of spinal cord injury. World Neurosurg. 2021;150:1–8. doi:10.1016/j.wneu.2021.02.116
   PubMed Web of Science ®Google Scholar
• Sultan I, Lamba N, Liew A, et al. The safety and efficacy of steroid treatment for acute spinal cord injury: a Systematic Review and meta-analysis. Heliyon. 2020;6(2):e03414. doi:10.1016/j.heliyon.2020.e03414
   PubMed Web of Science ®Google Scholar
• Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics. 2018;15(3):541–553. doi:10.1007/s13311-018-0631-6
   PubMed Web of Science ®Google Scholar
• Herbert FJ, Bharathi D, Suresh S, David E, Kumar S. Regenerative potential of Stem cell-derived extracellular vesicles in spinal cord injury (SCI). Curr Stem Cell Res Ther. 2021. doi:10.2174/1574888X16666210923113658
   Web of Science ®Google Scholar
• Ong WK, Chakraborty S, Sugii S. Adipose tissue: understanding the heterogeneity of stem cells for regenerative medicine. Biomolecules. 2021;11(7):918. doi:10.3390/biom11070918
   PubMed Web of Science ®Google Scholar
• Hu C, Li L. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation. J Transl Med. 2019;17(1):412. doi:10.1186/s12967-019-02167-0
   PubMed Web of Science ®Google Scholar
• Iwatani S, Yoshida M, Yamana K, et al. Isolation and characterization of human umbilical cord-derived mesenchymal stem cells from preterm and term infants. J Vis Exp. 2019;143:e58806.
   Google Scholar
• Fu Q, Zhang Q, Jia LY, et al. Isolation and characterization of rat mesenchymal stem cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood. Cells Tissues Organs. 2015;201(6):412–422. doi:10.1159/000445855
   PubMed Web of Science ®Google Scholar
• Tian J, Hong Y, Zhu Q, et al. Mesenchymal stem cell enhances the function of MDSCs in experimental Sjogren syndrome. Front Immunol. 2020;11:604607. doi:10.3389/fimmu.2020.604607
   PubMed Web of Science ®Google Scholar
• Lv X, Wang L, Zou X, Huang S. Umbilical cord mesenchymal stem cell therapy for regenerative treatment of rheumatoid arthritis: opportunities and challenges. Drug Des Devel Ther. 2021;15:3927–3936. doi:10.2147/DDDT.S323107
   PubMed Web of Science ®Google Scholar
• Song EM, Joo YH, Choe AR, et al. Three-dimensional culture method enhances the therapeutic efficacies of tonsil-derived mesenchymal stem cells in murine chronic colitis model. Sci Rep. 2021;11(1):19589. doi:10.1038/s41598-021-98711-4
   PubMed Web of Science ®Google Scholar
• Xiao X, Li W, Rong D, et al. Human umbilical cord mesenchymal stem cells-derived extracellular vesicles facilitate the repair of spinal cord injury via the miR-29b-3p/PTEN/Akt/mTOR axis. Cell Death Discov. 2021;7(1):212. doi:10.1038/s41420-021-00572-3
   PubMed Web of Science ®Google Scholar
• Boido M, Ghibaudi M, Gentile P, Favaro E, Fusaro R, Tonda-Turo C. Chitosan-based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment. Sci Rep. 2019;9(1):6402. doi:10.1038/s41598-019-42848-w
   PubMed Web of Science ®Google Scholar
• Maldonado-Lasuncion I, Verhaagen J, Oudega M. Mesenchymal stem cell-macrophage choreography supporting spinal cord repair. Neurotherapeutics. 2018;15(3):578–587. doi:10.1007/s13311-018-0629-0
   PubMed Web of Science ®Google Scholar
• Gadani SP, Walsh JT, Lukens JR, Kipnis J. Dealing with danger in the CNS: the response of the immune system to injury. Neuron. 2015;87(1):47–62. doi:10.1016/j.neuron.2015.05.019
   PubMed Web of Science ®Google Scholar
• Yao C, Cao X, Yu B. Revascularization after traumatic spinal cord injury. Front Physiol. 2021;12:631500. doi:10.3389/fphys.2021.631500
   PubMed Web of Science ®Google Scholar
• Matsushita T, Lankford KL, Arroyo EJ, et al. Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol. 2015;267:152–164. doi:10.1016/j.expneurol.2015.03.001
   PubMed Web of Science ®Google Scholar
• Xin W, Qiang S, Jianing D, et al. Human bone marrow mesenchymal stem cell-derived exosomes attenuate blood-spinal cord barrier disruption via the TIMP2/MMP pathway after acute spinal cord injury. Mol Neurobiol. 2021;58(12):6490–6504. doi:10.1007/s12035-021-02565-w
   PubMed Web of Science ®Google Scholar
• Al Mamun A, Wu Y, Monalisa I, et al. Role of pyroptosis in spinal cord injury and its therapeutic implications. J Adv Res. 2021;28:97–109. doi:10.1016/j.jare.2020.08.004
   PubMed Web of Science ®Google Scholar
• Fan H, Tang HB, Chen Z, et al. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury. J Neuroinflammation. 2020;17(1):295. doi:10.1186/s12974-020-01973-4
   PubMed Web of Science ®Google Scholar
• Ji H, Zhang Y, Chen C, et al. D-dopachrome tautomerase activates COX2/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury. J Neuroinflammation. 2021;18(1):130. doi:10.1186/s12974-021-02186-z
   PubMed Web of Science ®Google Scholar
• Gaudet AD, Fonken LK. Glial cells shape pathology and repair after spinal cord injury. Neurotherapeutics. 2018;15(3):554–577.
   PubMed Web of Science ®Google Scholar
• Takata F, Nakagawa S, Matsumoto J, Dohgu S. Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction. Front Cell Neurosci. 2021;15:661838. doi:10.3389/fncel.2021.661838
   PubMed Web of Science ®Google Scholar
• Khadka B, Lee JY, Kim KT, Bae JS. Recent progress in therapeutic drug delivery systems for treatment of traumatic CNS injuries. Future Med Chem. 2020;12(19):1759–1778. doi:10.4155/fmc-2020-0178
   PubMed Web of Science ®Google Scholar
• Dolma S, Kumar H. Neutrophil, extracellular matrix components, and their interlinked action in promoting secondary pathogenesis after spinal cord injury. Mol Neurobiol. 2021;58(9):4652–4665. doi:10.1007/s12035-021-02443-5
   PubMed Web of Science ®Google Scholar
• Zivkovic S, Ayazi M, Hammel G, Ren Y. For better or for worse: a look into neutrophils in traumatic spinal cord injury. Front Cell Neurosci. 2021;15:648076. doi:10.3389/fncel.2021.648076
   PubMed Web of Science ®Google Scholar
• Hassanzadeh S, Jalessi M, Jameie SB, et al. More attention on glial cells to have better recovery after spinal cord injury. Biochem Biophys Rep. 2021;25:100905. doi:10.1016/j.bbrep.2020.100905
   PubMedGoogle Scholar
• Fleming JC, Norenberg MD, Ramsay DA, et al. The cellular inflammatory response in human spinal cords after injury. Brain. 2006;129(Pt 12):3249–3269. doi:10.1093/brain/awl296
   PubMed Web of Science ®Google Scholar
• Ma SF, Chen YJ, Zhang JX, et al. Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury. Brain Behav Immun. 2015;45:157–170. doi:10.1016/j.bbi.2014.11.007
   PubMed Web of Science ®Google Scholar
• Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010;133(2):433–447. doi:10.1093/brain/awp322
   PubMed Web of Science ®Google Scholar
• Anjum A, Yazid MD, Fauzi Daud M, et al. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 2020;21(20):7533. doi:10.3390/ijms21207533
   PubMed Web of Science ®Google Scholar
• Garcia E, Aguilar-Cevallos J, Silva-Garcia R, Ibarra A. Cytokine and growth factor activation in vivo and in vitro after spinal cord injury. Mediators Inflamm. 2016;2016:1–21. doi:10.1155/2016/9476020
   Web of Science ®Google Scholar
• Kiran S, Dwivedi P, Kumar V, Price RL, Singh UP. Immunomodulation and biomaterials: key players to repair volumetric muscle loss. Cells. 2021;10(8):2016. doi:10.3390/cells10082016
   PubMed Web of Science ®Google Scholar
• Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1–11. doi:10.1016/j.brainres.2014.12.045
   PubMed Web of Science ®Google Scholar
• Nosbaum A, Prevel N, Truong HA, et al. Cutting edge: regulatory T cells facilitate cutaneous wound healing. J Immunol. 2016;196(5):2010–2014. doi:10.4049/jimmunol.1502139
   PubMed Web of Science ®Google Scholar
• Deonarine K, Panelli MC, Stashower ME, et al. Gene expression profiling of cutaneous wound healing. J Transl Med. 2007;5(1):11. doi:10.1186/1479-5876-5-11
   PubMed Web of Science ®Google Scholar
• Nakazaki M, Morita T, Lankford KL, Askenase PW, Kocsis JD. Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-beta upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury. J Extracell Vesicles. 2021;10(11):e12137. doi:10.1002/jev2.12137
   PubMed Web of Science ®Google Scholar
• Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, et al. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Exp Neurol. 2021;347:113889. doi:10.1016/j.expneurol.2021.113889
   PubMed Web of Science ®Google Scholar
• Chio JCT, Wang J, Surendran V, et al. Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier. Neurobiol Dis. 2021;148:105187. doi:10.1016/j.nbd.2020.105187
   PubMed Web of Science ®Google Scholar
• Gaire BP, Choi JW. Critical roles of lysophospholipid receptors in activation of neuroglia and their neuroinflammatory responses. Int J Mol Sci. 2021;22(15):7864. doi:10.3390/ijms22157864
   PubMed Web of Science ®Google Scholar
• Francos-Quijorna I, Santos-Nogueira E, Gronert K, et al. Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury. J Neurosci. 2017;37(48):11731–11743. doi:10.1523/JNEUROSCI.1395-17.2017
   PubMed Web of Science ®Google Scholar
• Fan R, Zhang Y, Botchway BOA, Liu X. Resveratrol can attenuate astrocyte activation to treat spinal cord injury by inhibiting inflammatory responses. Mol Neurobiol. 2021;58(11):5799–5813. doi:10.1007/s12035-021-02509-4
   PubMed Web of Science ®Google Scholar
• Zhang H, Younsi A, Zheng G, et al. Sonic Hedgehog modulates the inflammatory response and improves functional recovery after spinal cord injury in a thoracic contusion-compression model. Eur Spine J. 2021;30(6):1509–1520. doi:10.1007/s00586-021-06796-2
   PubMed Web of Science ®Google Scholar
• Brockie S, Hong J, Fehlings MG. The role of microglia in modulating neuroinflammation after spinal cord injury. Int J Mol Sci. 2021;22(18):9706. doi:10.3390/ijms22189706
   PubMed Web of Science ®Google Scholar
• Gaojian T, Dingfei Q, Linwei L, et al. Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway. Cell Death Discovery. 2020;6(1):97. doi:10.1038/s41420-020-00333-8
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29(43):13435–13444. doi:10.1523/JNEUROSCI.3257-09.2009
   PubMed Web of Science ®Google Scholar
• Akhmetzyanova E, Kletenkov K, Mukhamedshina Y, Rizvanov A. Different approaches to modulation of microglia phenotypes after spinal cord injury. Front Syst Neurosci. 2019;13:37. doi:10.3389/fnsys.2019.00037
   PubMed Web of Science ®Google Scholar
• Milich LM, Ryan CB, Lee JK. The origin, fate, and contribution of macrophages to spinal cord injury pathology. Acta Neuropathol. 2019;137(5):785–797. doi:10.1007/s00401-019-01992-3
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958–969. doi:10.1038/nri2448
   PubMed Web of Science ®Google Scholar
• Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12(3):231–238. doi:10.1038/ni.1990
   PubMed Web of Science ®Google Scholar
• Guo J, Wang H, Li L, Yuan Y, Shi X, Hou S. Treatment with IL-19 improves locomotor functional recovery after contusion trauma to the spinal cord. Br J Pharmacol. 2018;175(13):2611–2621. doi:10.1111/bph.14193
   PubMed Web of Science ®Google Scholar
• Ghosh M, Xu Y, Pearse DD. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. J Neuroinflammation. 2016;13(1):9. doi:10.1186/s12974-015-0463-9
   PubMed Web of Science ®Google Scholar
• Li M, Xu J, Mei X, et al. Regulatory effects of dermal papillary pluripotent stem cells on polarization of macrophages from M1 to M2 phenotype in vitro. Transpl Immunol. 2019;52:57–67. doi:10.1016/j.trim.2018.11.003
   PubMed Web of Science ®Google Scholar
• Duan K, Liu S, Yi Z, et al. S100-beta aggravates spinal cord injury via activation of M1 macrophage phenotype. J Musculoskelet Neuronal Interact. 2021;21(3):401–412.
   PubMed Web of Science ®Google Scholar
• Hart CG, Karimi-Abdolrezaee S. Recent insights on astrocyte mechanisms in CNS homeostasis, pathology, and repair. J Neurosci Res. 2021;99(10):2427–2462. doi:10.1002/jnr.24922
   PubMed Web of Science ®Google Scholar
• Ahmed A, Patil AA, Agrawal DK. Immunobiology of spinal cord injuries and potential therapeutic approaches. Mol Cell Biochem. 2018;441(1–2):181–189. doi:10.1007/s11010-017-3184-9
   PubMed Web of Science ®Google Scholar
• Mussbacher M, Salzmann M, Brostjan C, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol. 2019;10:85. doi:10.3389/fimmu.2019.00085
   PubMed Web of Science ®Google Scholar
• Tang R, Botchway BOA, Meng Y, et al. The inhibition of inflammatory signaling pathway by secretory leukocyte protease inhibitor can improve spinal cord injury. Cell Mol Neurobiol. 2020;40(7):1067–1073. doi:10.1007/s10571-020-00799-1
   PubMed Web of Science ®Google Scholar
• Xu L, Botchway BOA, Zhang S, Zhou J, Liu X. Inhibition of NF-κB signaling pathway by resveratrol improves spinal cord injury. Front Neurosci. 2018;12:690. doi:10.3389/fnins.2018.00690
   PubMed Web of Science ®Google Scholar
• Brambilla R, Bracchi-Ricard V, Hu W-H, et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med. 2005;202(1):145–156. doi:10.1084/jem.20041918
   PubMed Web of Science ®Google Scholar
• Brambilla R, Hurtado A, Persaud T, et al. Transgenic inhibition of astroglial NF-κB leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem. 2009;110(2):765–778. doi:10.1111/j.1471-4159.2009.06190.x
   PubMed Web of Science ®Google Scholar
• Khorooshi R, Babcock AA, Owens T. NF-κB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol. 2008;181(10):7284–7291. doi:10.4049/jimmunol.181.10.7284
   PubMed Web of Science ®Google Scholar
• Yuan J, Liu W, Zhu H, et al. Curcumin inhibits glial scar formation by suppressing astrocyte-induced inflammation and fibrosis in vitro and in vivo. Brain Res. 2017;1655:90–103. doi:10.1016/j.brainres.2016.11.002
   PubMed Web of Science ®Google Scholar
• Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature. 2016;532(7598):195–200. doi:10.1038/nature17623
   PubMed Web of Science ®Google Scholar
• Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391–6410. doi:10.1523/JNEUROSCI.6221-11.2012
   PubMed Web of Science ®Google Scholar
• Escartin C, Galea E, Lakatos A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312–325. doi:10.1038/s41593-020-00783-4
   PubMed Web of Science ®Google Scholar
• Li X, Li M, Tian L, Chen J, Liu R, Ning B. Reactive astrogliosis: implications in spinal cord injury progression and therapy. Oxid Med Cell Longev. 2020;2020:9494352. doi:10.1155/2020/9494352
   PubMed Web of Science ®Google Scholar
• Zou HJ, Guo SW, Zhu L, Xu X, Liu JB. Methylprednisolone induces neuro-protective effects via the inhibition of A1 astrocyte activation in traumatic spinal cord injury mouse models. Front Neurosci. 2021;15:628917. doi:10.3389/fnins.2021.628917
   PubMed Web of Science ®Google Scholar
• Lana D, Ugolini F, Nosi D, Wenk GL, Giovannini MG. The emerging role of the interplay among astrocytes, microglia, and neurons in the hippocampus in health and disease. Front Aging Neurosci. 2021;13:651973. doi:10.3389/fnagi.2021.651973
   PubMed Web of Science ®Google Scholar
• Kisucka A, Bimbova K, Bacova M, Galik J, Lukacova N. Activation of neuroprotective microglia and astrocytes at the lesion site and in the adjacent segments is crucial for spontaneous locomotor recovery after spinal cord injury. Cells. 2021;10(8):1943. doi:10.3390/cells10081943
   PubMed Web of Science ®Google Scholar
• Liu LR, Liu JC, Bao JS, Bai QQ, Wang GQ. Interaction of microglia and astrocytes in the neurovascular unit. Front Immunol. 2020;11:1024. doi:10.3389/fimmu.2020.01024
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46(6):957–967. doi:10.1016/j.immuni.2017.06.006
   PubMed Web of Science ®Google Scholar
• Boghdadi AG, Teo L, Bourne JA. The neuroprotective role of reactive astrocytes after central nervous system injury. J Neurotrauma. 2020;37(5):681–691. doi:10.1089/neu.2019.6938
   PubMed Web of Science ®Google Scholar
• Xu L, Ye X, Wang Q, et al. T‐cell infiltration, contribution and regulation in the central nervous system post‐traumatic injury. Cell Prolif. 2021;54(8):e13092. doi:10.1111/cpr.13092
   PubMed Web of Science ®Google Scholar
• Duffy MM, Ritter T, Ceredig R, Griffin MD. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther. 2011;2(4):34. doi:10.1186/scrt75
   PubMed Web of Science ®Google Scholar
• Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 2015;72(2):146–153. doi:10.1016/j.cyto.2014.12.027
   PubMed Web of Science ®Google Scholar
• Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63(1–3):3–10. doi:10.1007/s12026-015-8698-1
   PubMed Web of Science ®Google Scholar
• Hu JG, Shi LL, Chen YJ, et al. Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord. Exp Neurol. 2016;277:190–201. doi:10.1016/j.expneurol.2016.01.002
   PubMed Web of Science ®Google Scholar
• Chaudhry SR, Kahlert UD, Kinfe TM, et al. Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications. Sci Rep. 2021;11(1):14226.
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100(6):655–669. doi:10.1016/S0092-8674(00)80702-3
   PubMed Web of Science ®Google Scholar
• Butcher MJ, Zhu J. Recent advances in understanding the Th1/Th2 effector choice. Fac Rev. 2021;10:30. doi:10.12703/r/10-30
   PubMedGoogle Scholar
• Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5–17. doi:10.1016/j.cyto.2014.09.011
   PubMed Web of Science ®Google Scholar
• Rahimi K, Ahmadi A, Hassanzadeh K, et al. Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states. Autoimmun Rev. 2019;18(7):738–748. doi:10.1016/j.autrev.2019.05.012
   PubMed Web of Science ®Google Scholar
• Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol. 2007;184(1–2):100–112. doi:10.1016/j.jneuroim.2006.11.019
   PubMed Web of Science ®Google Scholar
• Qu N, Xu M, Mizoguchi I, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013:968549. doi:10.1155/2013/968549
   PubMed Web of Science ®Google Scholar
• Liu D, Liu B, Lin C, Gu J. Imbalance of peripheral lymphocyte subsets in patients with ankylosing spondylitis: a meta-analysis. Front Immunol. 2021;12:696973. doi:10.3389/fimmu.2021.696973
   PubMed Web of Science ®Google Scholar
• Tuzlak S, Dejean AS, Iannacone M, et al. Repositioning TH cell polarization from single cytokines to complex help. Nat Immunol. 2021;22(10):1210–1217. doi:10.1038/s41590-021-01009-w
   PubMed Web of Science ®Google Scholar
• Carvalheiro T, Rafael-Vidal C, Malvar-Fernandez B, et al. Semaphorin4A-plexin D1 axis induces Th2 and Th17 while represses Th1 skewing in an autocrine manner. Int J Mol Sci. 2020;21(18):6965. doi:10.3390/ijms21186965
   PubMed Web of Science ®Google Scholar
• Lin W, Chen W, Liu W, Xu Z, Zhang L. Sirtuin4 suppresses the anti-neuroinflammatory activity of infiltrating regulatory T cells in the traumatically injured spinal cord. Immunology. 2019;158(4):362–374. doi:10.1111/imm.13123
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490–500. doi:10.1038/nri2785
   PubMed Web of Science ®Google Scholar
• Chen J, Chen YQ, Shi YJ, et al. VX-765 reduces neuroinflammation after spinal cord injury in mice. Neural Regen Res. 2021;16(9):1836–1847. doi:10.4103/1673-5374.306096
   PubMed Web of Science ®Google Scholar
• Zhou Z, Tian X, Mo B, et al. Adipose mesenchymal stem cell transplantation alleviates spinal cord injury-induced neuroinflammation partly by suppressing the Jagged1/Notch pathway. Stem Cell Res Ther. 2020;11(1):212. doi:10.1186/s13287-020-01724-5
   PubMed Web of Science ®Google Scholar
• Urdzíková L, Růžička J, LaBagnara M, et al. Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat. Int J Mol Sci. 2014;15(7):11275–11293. doi:10.3390/ijms150711275
   PubMed Web of Science ®Google Scholar
• Tsumuraya T, Ohtaki H, Song D, et al. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP). J Neuroinflammation. 2015;12:35. doi:10.1186/s12974-015-0252-5
   PubMed Web of Science ®Google Scholar
• Nakajima H, Uchida K, Guerrero AR, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma. 2012;29(8):1614–1625. doi:10.1089/neu.2011.2109
   PubMed Web of Science ®Google Scholar
• Maeda Y, Otsuka T, Takeda M, et al. Transplantation of rat cranial bone-derived mesenchymal stem cells promotes functional recovery in rats with spinal cord injury. Sci Rep. 2021;11(1):21907. doi:10.1038/s41598-021-01490-1
   PubMed Web of Science ®Google Scholar
• Bao CS, Li XL, Liu L, Wang B, Yang FB, Chen LG. Transplantation of Human umbilical cord mesenchymal stem cells promotes functional recovery after spinal cord injury by blocking the expression of IL-7. Eur Rev Med Pharmacol Sci. 2018;22(19):6436–6447. doi:10.26355/eurrev_201810_16056
   PubMed Web of Science ®Google Scholar
• Papa S, Vismara I, Mariani A, et al. Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury. J Control Release. 2018;278:49–56. doi:10.1016/j.jconrel.2018.03.034
   PubMed Web of Science ®Google Scholar
• Matsubara K, Matsushita Y, Sakai K, et al. Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity. J Neurosci. 2015;35(6):2452–2464. doi:10.1523/JNEUROSCI.4088-14.2015
   PubMed Web of Science ®Google Scholar
• Fu Q, Liu Y, Liu X, et al. Engrafted peripheral blood-derived mesenchymal stem cells promote locomotive recovery in adult rats after spinal cord injury. Am J Transl Res. 2017;9(9):3950–3966.
   PubMed Web of Science ®Google Scholar
• Nitzsche F, Muller C, Lukomska B, Jolkkonen J, Deten A, Boltze J. Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells. 2017;35(6):1446–1460. doi:10.1002/stem.2614
   PubMed Web of Science ®Google Scholar
• Ferrini E, Stellari FF, Franceschi V, et al. Persistency of mesenchymal stromal/stem cells in lungs. Front Cell Dev Biol. 2021;9:709225. doi:10.3389/fcell.2021.709225
   PubMed Web of Science ®Google Scholar
• Markov A, Thangavelu L, Aravindhan S, et al. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther. 2021;12(1):192. doi:10.1186/s13287-021-02265-1
   PubMed Web of Science ®Google Scholar
• Hassanshahi G, Roohi MA, Esmaeili SA, Pourghadamyari H, Nosratabadi R. Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients. Cytokine. 2021;148:155706. doi:10.1016/j.cyto.2021.155706
   PubMed Web of Science ®Google Scholar
• Li Q, Lian Y, Deng Y, et al. mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD. Mol Ther Nucleic Acids. 2021;26:222–236. doi:10.1016/j.omtn.2021.07.009
   PubMedGoogle Scholar
• Andrzejewska A, Dabrowska S, Lukomska B, Janowski M. Mesenchymal stem cells for neurological disorders. Adv Sci. 2021;8(7):2002944. doi:10.1002/advs.202002944
   Web of Science ®Google Scholar
• Johnson LDV, Pickard MR, Johnson WEB. The comparative effects of mesenchymal stem cell transplantation therapy for spinal cord injury in humans and animal models: a systematic review and meta-analysis. Biology. 2021;10(3):230. doi:10.3390/biology10030230
   PubMed Web of Science ®Google Scholar
• Lindsay SL, Barnett SC. Therapeutic potential of niche-specific mesenchymal stromal cells for spinal cord injury repair. Cells. 2021;10(4):901. doi:10.3390/cells10040901
   PubMed Web of Science ®Google Scholar
• Silva-Carvalho AE, Cardoso MH, Alencar-Silva T, et al. Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells. Pharmacol Ther. 2021:108021. doi:10.1016/j.pharmthera.2021.108021
   PubMed Web of Science ®Google Scholar
• Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic properties of mesenchymal stromal/stem cells: the need of cell priming for cell-free therapies in regenerative medicine. Int J Mol Sci. 2021;22(2):763. doi:10.3390/ijms22020763
   PubMed Web of Science ®Google Scholar
• Lavoie JR, Rosu-Myles M. Uncovering the secretes of mesenchymal stem cells. Biochimie. 2013;95(12):2212–2221. doi:10.1016/j.biochi.2013.06.017
   PubMed Web of Science ®Google Scholar
• Sykova E, Cizkova D, Kubinova S. Mesenchymal stem cells in treatment of spinal cord injury and amyotrophic lateral sclerosis. Front Cell Dev Biol. 2021;9:695900. doi:10.3389/fcell.2021.695900
   PubMed Web of Science ®Google Scholar
• Lv B, Zhang X, Yuan J, et al. Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury. Stem Cell Res Ther. 2021;12(1):36. doi:10.1186/s13287-020-02090-y
   PubMed Web of Science ®Google Scholar
• Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6(12):2173–2185. doi:10.1002/sctm.17-0129
   PubMed Web of Science ®Google Scholar
• Antonios JP, Farah GJ, Cleary DR, Martin JR, Ciacci JD, Pham MH. Immunosuppressive mechanisms for stem cell transplant survival in spinal cord injury. Neurosurg Focus. 2019;46(3):E9. doi:10.3171/2018.12.FOCUS18589
   PubMed Web of Science ®Google Scholar
• Chen D, Zeng W, Fu Y, Gao M, Lv G. Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model. Int J Clin Exp Pathol. 2015;8(10):11957–11969.
   PubMed Web of Science ®Google Scholar
• An N, Yang J, Wang H, et al. Mechanism of mesenchymal stem cells in spinal cord injury repair through macrophage polarization. Cell Biosci. 2021;11(1):41. doi:10.1186/s13578-021-00554-z
   PubMed Web of Science ®Google Scholar
• Yang R, Gao H, Chen L, et al. Effect of peripheral blood-derived mesenchymal stem cells on macrophage polarization and Th17/Treg balance in vitro. Regen Ther. 2020;14:275–283. doi:10.1016/j.reth.2020.03.008
   PubMed Web of Science ®Google Scholar
• Eggenhofer E, Hoogduijn MJ. Mesenchymal stem cell-educated macrophages. Transplant Res. 2012;1(1):12. doi:10.1186/2047-1440-1-12
   PubMedGoogle Scholar
• Cho DI, Kim MR, Jeong HY, et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med. 2014;46:e70. doi:10.1038/emm.2013.135
   PubMed Web of Science ®Google Scholar
• Selleri S, Bifsha P, Civini S, et al. Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming. Oncotarget. 2016;7(21):30193–30210. doi:10.18632/oncotarget.8623
   PubMedGoogle Scholar
• Takafuji Y, Hori M, Mizuno T, Harada-Shiba M. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice. Cardiovasc Res. 2019;115(6):1041–1051. doi:10.1093/cvr/cvy271
   PubMed Web of Science ®Google Scholar
• Sun G, Li G, Li D, et al. hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation. Mater Sci Eng C Mater Biol Appl. 2018;89:194–204. doi:10.1016/j.msec.2018.04.006
   PubMed Web of Science ®Google Scholar
• Zhai X, Chen K, Yang H, et al. Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury. J Nanobiotechnology. 2021;19(1):274. doi:10.1186/s12951-021-01022-z
   PubMed Web of Science ®Google Scholar
• Lee JR, Kyung JW, Kumar H, et al. Targeted delivery of mesenchymal stem cell-derived nanovesicles for spinal cord injury treatment. Int J Mol Sci. 2020;21(11):4185. doi:10.3390/ijms21114185
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation. Stem Cells. 2013;31(10):2042–2046. doi:10.1002/stem.1400
   PubMed Web of Science ®Google Scholar
• Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42–49. doi:10.1038/nm.1905
   PubMed Web of Science ®Google Scholar
• Francois M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2012;20(1):187–195. doi:10.1038/mt.2011.189
   PubMed Web of Science ®Google Scholar
• Song X, Xie S, Lu K, Wang C. Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation. 2015;38(2):485–492. doi:10.1007/s10753-014-9954-6
   PubMed Web of Science ®Google Scholar
• Braza F, Dirou S, Forest V, et al. Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma. Stem Cells. 2016;34(7):1836–1845. doi:10.1002/stem.2344
   PubMed Web of Science ®Google Scholar
• Melief SM, Geutskens SB, Fibbe WE, Roelofs H. Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica. 2013;98(6):888–895. doi:10.3324/haematol.2012.078055
   PubMed Web of Science ®Google Scholar
• Freytes DO, Kang JW, Marcos-Campos I, Vunjak-Novakovic G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem. 2013;114(1):220–229. doi:10.1002/jcb.24357
   PubMed Web of Science ®Google Scholar
• Maldonado-Lasuncion I, Haggerty AE, Okuda A, et al. The effect of inflammatory priming on the therapeutic potential of mesenchymal stromal cells for spinal cord repair. Cells. 2021;10(6):1316. doi:10.3390/cells10061316
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang Q, Chen QH, et al. Combination of G-CSF and AMD3100 improves the anti-inflammatory effect of mesenchymal stem cells on inducing M2 polarization of macrophages through NF-kappaB-IL1RA signaling pathway. Front Pharmacol. 2019;10:579. doi:10.3389/fphar.2019.00579
   PubMed Web of Science ®Google Scholar
• Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood. 2011;118(2):330–338. doi:10.1182/blood-2010-12-327353
   PubMed Web of Science ®Google Scholar
• Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–795. doi:10.1172/JCI59643
   PubMed Web of Science ®Google Scholar
• Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356(6337):513–519. doi:10.1126/science.aal3535
   PubMed Web of Science ®Google Scholar
• Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71–109. doi:10.1146/annurev-immunol-031210-101312
   PubMed Web of Science ®Google Scholar
• Qian D, Li L, Rong Y, et al. Blocking Notch signal pathway suppresses the activation of neurotoxic A1 astrocytes after spinal cord injury. Cell Cycle. 2019;18(21):3010–3029. doi:10.1080/15384101.2019.1667189
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–487. doi:10.1038/nature21029
   PubMed Web of Science ®Google Scholar
• Jiang D, Gong F, Ge X, et al. Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J Nanobiotechnology. 2020;18(1):105. doi:10.1186/s12951-020-00665-8
   PubMed Web of Science ®Google Scholar
• Schäfer S, Calas A-G, Vergouts M, Hermans E. Immunomodulatory influence of bone marrow-derived mesenchymal stem cells on neuroinflammation in astrocyte cultures. J Neuroimmunol. 2012;249(1–2):40–48. doi:10.1016/j.jneuroim.2012.04.018
   PubMed Web of Science ®Google Scholar
• Wang S, Jia Y, Cao X, et al. HUCMSCs transplantation combined with ultrashort wave therapy attenuates neuroinflammation in spinal cord injury through NUR77/ NF-kappaB pathway. Life Sci. 2021;267:118958. doi:10.1016/j.lfs.2020.118958
   PubMed Web of Science ®Google Scholar
• Wang L, Pei S, Han L, et al. Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NFkappaB P65 subunit in spinal cord injury. Cell Physiol Biochem. 2018;50(4):1535–1559. doi:10.1159/000494652
   PubMedGoogle Scholar
• Ceyzeriat K, Abjean L, Carrillo-de Sauvage MA, Ben Haim L, Escartin C. The complex STATes of astrocyte reactivity: how are they controlled by the JAK-STAT3 pathway? Neuroscience. 2016;330:205–218. doi:10.1016/j.neuroscience.2016.05.043
   PubMed Web of Science ®Google Scholar
• Gu Y, He M, Zhou X, et al. Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by suppressing apoptosis in astrocyte. Sci Rep. 2016;6:18587. doi:10.1038/srep18587
   PubMed Web of Science ®Google Scholar
• Norden DM, Fenn AM, Dugan A, Godbout JP. TGFbeta produced by IL-10 redirected astrocytes attenuates microglial activation. Glia. 2014;62(6):881–895. doi:10.1002/glia.22647
   PubMed Web of Science ®Google Scholar
• Luo K. Signaling cross talk between TGF-beta/Smad and other signaling pathways. Cold Spring Harb Perspect Biol. 2017;9(1):a022137. doi:10.1101/cshperspect.a022137
   PubMed Web of Science ®Google Scholar
• Liu R, Wang W, Wang S, Xie W, Li H, Ning B. microRNA-21 regulates astrocytic reaction post-acute phase of spinal cord injury through modulating TGF-beta signaling. Aging. 2018;10(6):1474–1488. doi:10.18632/aging.101484
   PubMedGoogle Scholar
• Li T, Liu T, Chen X, et al. Microglia induce the transformation of A1/A2 reactive astrocytes via the CXCR7/PI3K/Akt pathway in chronic post-surgical pain. J Neuroinflammation. 2020;17(1):211. doi:10.1186/s12974-020-01891-5
   PubMed Web of Science ®Google Scholar
• Liu F, Qiu H, Xue M, et al. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway. Stem Cell Res Ther. 2019;10(1):345. doi:10.1186/s13287-019-1447-y
   PubMed Web of Science ®Google Scholar
• Li X, Dong Y, Yin H, Qi Z, Wang D, Ren S. Mesenchymal stem cells induced regulatory dendritic cells from hemopoietic progenitor cells through Notch pathway and TGF-beta synergistically. Immunol Lett. 2020;222:49–57. doi:10.1016/j.imlet.2020.03.005
   PubMed Web of Science ®Google Scholar
• Luz-Crawford P, Kurte M, Bravo-Alegria J, et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013;4(3):65. doi:10.1186/scrt216
   PubMed Web of Science ®Google Scholar
• Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1191. doi:10.3389/fimmu.2019.01191
   PubMed Web of Science ®Google Scholar
• Mokarizadeh A, Delirezh N, Morshedi A, Mosayebi G, Farshid AA, Mardani K. Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett. 2012;147(1–2):47–54. doi:10.1016/j.imlet.2012.06.001
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, Tan SS, Choo AB, Lim SK. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23(11):1233–1244. doi:10.1089/scd.2013.0479
   PubMed Web of Science ®Google Scholar
• Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103(12):4619–4621. doi:10.1182/blood-2003-11-3909
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009–1016. doi:10.1038/ni.3002
   PubMed Web of Science ®Google Scholar
• Sato K, Ozaki K, Oh I, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109(1):228–234. doi:10.1182/blood-2006-02-002246
   PubMed Web of Science ®Google Scholar
• Bouffi C, Bony C, Courties G, Jorgensen C, Noel D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One. 2010;5(12):e14247. doi:10.1371/journal.pone.0014247
   PubMed Web of Science ®Google Scholar
• Matysiak M, Orlowski W, Fortak-Michalska M, Jurewicz A, Selmaj K. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J Neuroimmunol. 2011;233(1–2):106–111. doi:10.1016/j.jneuroim.2010.12.004
   PubMed Web of Science ®Google Scholar
• Selmani Z, Naji A, Zidi I, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells. 2008;26(1):212–222. doi:10.1634/stemcells.2007-0554
   PubMed Web of Science ®Google Scholar
• Wang K, Shi YJ, Song ZL, et al. Regulatory effect of rat bone marrow mesenchymal stem cells on Treg/Th17 immune balance in vitro. Mol Med Rep. 2020;21(5):2123–2130. doi:10.3892/mmr.2020.11019
   PubMed Web of Science ®Google Scholar
• Melief SM, Schrama E, Brugman MH, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31(9):1980–1991. doi:10.1002/stem.1432
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim SN, Jeon MS, Yi T, Song SU. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells. Sci Rep. 2017;7:44486. doi:10.1038/srep44486
   PubMed Web of Science ®Google Scholar
• Martinez AM, Goulart CO, Ramalho Bdos S, Oliveira JT, Almeida FM. Neurotrauma and mesenchymal stem cells treatment: from experimental studies to clinical trials. World J Stem Cells. 2014;6(2):179–194. doi:10.4252/wjsc.v6.i2.179
   PubMedGoogle Scholar
• Zhilai Z, Biling M, Sujun Q, et al. Preconditioning in lowered oxygen enhances the therapeutic potential of human umbilical mesenchymal stem cells in a rat model of spinal cord injury. Brain Res. 2016;1642:426–435. doi:10.1016/j.brainres.2016.04.025
   PubMed Web of Science ®Google Scholar
• Mammana S, Gugliandolo A, Cavalli E, et al. Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury. J Tissue Eng Regen Med. 2019;13(7):1109–1121. doi:10.1002/term.2857
   PubMed Web of Science ®Google Scholar
• Wang W, Huang X, Lin W, et al. Hypoxic preconditioned bone mesenchymal stem cells ameliorate spinal cord injury in rats via improved survival and migration. Int J Mol Med. 2018;42(5):2538–2550. doi:10.3892/ijmm.2018.3810
   PubMed Web of Science ®Google Scholar
• Noori L, Arabzadeh S, Mohamadi Y, et al. Intrathecal administration of the extracellular vesicles derived from human Wharton’s jelly stem cells inhibit inflammation and attenuate the activity of inflammasome complexes after spinal cord injury in rats. Neurosci Res. 2021;170:87–98. doi:10.1016/j.neures.2020.07.011
   PubMed Web of Science ®Google Scholar
• Liu W, Rong Y, Wang J, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation. 2020;17(1):47. doi:10.1186/s12974-020-1726-7
   PubMed Web of Science ®Google Scholar
• Lankford KL, Arroyo EJ, Nazimek K, Bryniarski K, Askenase PW, Kocsis JD. Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord. PLoS One. 2018;13(1):e0190358. doi:10.1371/journal.pone.0190358
   PubMed Web of Science ®Google Scholar
• Fan L, Dong J, He X, Zhang C, Zhang T. Bone marrow mesenchymal stem cells-derived exosomes reduce apoptosis and inflammatory response during spinal cord injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Hum Exp Toxicol. 2021;40(10):1612–1623. doi:10.1177/09603271211003311
   PubMed Web of Science ®Google Scholar
• Shang AJ, Hong SQ, Xu Q, et al. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res. 2011;1391:102–113. doi:10.1016/j.brainres.2011.03.019
   PubMed Web of Science ®Google Scholar
• Li G, Che MT, Zeng X, et al. Neurotrophin-3 released from implant of tissue-engineered fibroin scaffolds inhibits inflammation, enhances nerve fiber regeneration, and improves motor function in canine spinal cord injury. J Biomed Mater Res A. 2018;106(8):2158–2170. doi:10.1002/jbm.a.36414
   PubMed Web of Science ®Google Scholar
• Allahdadi KJ, De santana TA, Santos GC, et al. IGF-1 overexpression improves mesenchymal stem cell survival and promotes neurological recovery after spinal cord injury. Stem Cell Res Ther. 2019;10(1):146. doi:10.1186/s13287-019-1223-z
   PubMed Web of Science ®Google Scholar
• Liu W, Wang Y, Gong F, et al. Exosomes derived from bone mesenchymal stem cells repair traumatic spinal cord injury by suppressing the activation of A1 neurotoxic reactive astrocytes. J Neurotrauma. 2019;36(3):469–484. doi:10.1089/neu.2018.5835
   PubMed Web of Science ®Google Scholar
• Li Z, Wang Q, Hu H, Zheng W, Gao C. Research advances of biomaterials-based microenvironment-regulation therapies for repair and regeneration of spinal cord injury. Biomed Mater. 2021;16(5):052002. doi:10.1088/1748-605X/ac1d3c
   Web of Science ®Google Scholar
• Ha XQ, Yang B, Hou HJ, Cai XL, Xiong WY, Wei XP. Protective effect of rhodioloside and bone marrow mesenchymal stem cells infected with HIF-1-expressing adenovirus on acute spinal cord injury. Neural Regen Res. 2020;15(4):690–696. doi:10.4103/1673-5374.266920
   PubMed Web of Science ®Google Scholar
• Amiri F, Jahanian-Najafabadi A, Roudkenar MH. In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments: in vitro augmentation of mesenchymal stem cells viability. Cell Stress Chaperones. 2015;20(2):237–251. doi:10.1007/s12192-014-0560-1
   PubMed Web of Science ®Google Scholar
• Yang Y, Lee EH, Yang Z. Hypoxia conditioned mesenchymal stem cells in tissue regeneration application. Tissue Eng Part B Rev. 2021. doi:10.1089/ten.TEB.2021.0145
   Web of Science ®Google Scholar
• Philipp D, Suhr L, Wahlers T, Choi YH, Paunel-Gorgulu A. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization. Stem Cell Res Ther. 2018;9(1):286. doi:10.1186/s13287-018-1039-2
   PubMed Web of Science ®Google Scholar
• Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450(7169):566–569. doi:10.1038/nature06306
   PubMed Web of Science ®Google Scholar
• Guo H, Zhao N, Gao H, He X. Mesenchymal stem cells overexpressing interleukin-35 propagate immunosuppressive effects in mice. Scand J Immunol. 2017;86(5):389–395. doi:10.1111/sji.12613
   PubMed Web of Science ®Google Scholar
• Dooley D, Lemmens E, Vangansewinkel T, et al. Cell-based delivery of interleukin-13 directs alternative activation of macrophages resulting in improved functional outcome after spinal cord injury. Stem Cell Reports. 2016;7(6):1099–1115. doi:10.1016/j.stemcr.2016.11.005
   PubMed Web of Science ®Google Scholar